Pharmacovigilance services at RMPDC were initiated within the context of 50 years of exhaustive research in drug safety, monitoring and surveillance, public health, and medical information.
RMPDC has been providing pharmacovigilance services for nine years, and continues to benefit from the knowledge base created and augmented by the drug safety research services.
These services include:
- Streamlined post-launch activities such as processing AE's, follow-up and rule outs
- PV Safety Database Support / Monitoring
- Safety Signaling
- Case Processing
- Literature Surveillance